Cargando…

Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy.

"A key requirement for the effective implementation of the therapeutic approach, based on the intravenous administration of radiolabelled compounds (radionuclide therapy), is the sufficient availability of radionuclides with appropriate physical characteristics. Based on their nuclear propertie...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Vienna : International Atomic Energy Agency, 2015.
Colección:IAEA radioisotopes and radiopharmaceuticals series ; no. 5,
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn907647895
003 OCoLC
005 20240329122006.0
006 m o d i
007 cr un|||||||||
008 150420s2015 au a ob i000 0 eng d
040 |a COD  |b eng  |e rda  |e pn  |c COD  |d EBLCP  |d MERUC  |d OCLCF  |d EZ9  |d OCLCQ  |d YDX  |d OCLCQ  |d K6U  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 1123187029  |a 1124565463 
020 |a 9201210191  |q (electronic bk.) 
020 |a 9789201210197  |q (electronic bk.) 
020 |z 9789201038142 
020 |z 9201038143 
029 1 |a AU@  |b 000066432406 
035 |a (OCoLC)907647895  |z (OCoLC)1123187029  |z (OCoLC)1124565463 
050 4 |a RM852  |b .Y88 2015 
082 0 4 |a 616.07575  |2 23 
049 |a UAMI 
245 0 0 |a Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy. 
264 1 |a Vienna :  |b International Atomic Energy Agency,  |c 2015. 
300 |a 1 online resource (301 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a IAEA radioisotopes and radiopharmaceuticals series,  |x 2077-6462 ;  |v no. 5 
500 |a "STI/PUB/1662"--Title page verso 
500 |a "January 2015"--Title page verso 
504 |a Includes bibliographical references. 
520 |a "A key requirement for the effective implementation of the therapeutic approach, based on the intravenous administration of radiolabelled compounds (radionuclide therapy), is the sufficient availability of radionuclides with appropriate physical characteristics. Based on their nuclear properties, 188Re and 90Y are considered among the most interesting radionuclides for therapy. Furthermore, they are produced through portable generators, which provide a crucial advantage toward ensuring a worldwide distribution of these radionuclides. This publication illustrates recent studies aimed at investigating efficient quality control methods to ensure both the radionuclidic purity of generator eluates, and the proper preparation of new target specific 188Re and 90Y radiopharmaceuticals for various clinical applications."--Publisher's description 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Radiopharmaceuticals. 
650 0 |a Yttrium  |x Isotopes  |x Therapeutic use. 
650 0 |a Rhenium  |x Isotopes  |x Therapeutic use. 
650 0 |a Radioisotopes. 
650 0 |a Radionuclide generators. 
650 2 |a Radiopharmaceuticals 
650 2 |a Radioisotopes 
650 2 |a Radionuclide Generators 
650 6 |a Radiopharmaceutiques. 
650 6 |a Yttrium  |x Isotopes  |x Emploi en thérapeutique. 
650 6 |a Isotopes radioactifs. 
650 6 |a Générateurs de radioéléments. 
650 7 |a Radioisotopes  |2 fast 
650 7 |a Radionuclide generators  |2 fast 
650 7 |a Radiopharmaceuticals  |2 fast 
650 7 |a Yttrium  |x Isotopes  |x Therapeutic use  |2 fast 
710 2 |a International Atomic Energy Agency,  |e issuing body. 
776 0 8 |i Print version:  |t Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy.  |d Vienna : International Atomic Energy Agency, 2015  |z 9789201038142  |w (OCoLC)907172083 
830 0 |a IAEA radioisotopes and radiopharmaceuticals series ;  |v no. 5,  |x 2077-6462 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4853249  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL4853249 
938 |a YBP Library Services  |b YANK  |n 16497552 
994 |a 92  |b IZTAP